Disorders of the basal ganglia such as Parkinson's disease (PD) and Huntington's disease are commonly thought of primarily as motor disorders; however, the cognitive symptoms of these diseases such as executive dysfunction, learning, memory and attention deficits are prominent and often more disabling than the hallmark motor symptoms. Cognitive features of PD are often neglected in preclinical studies of PD, likely due to the lack of available animal models to study them. Aphakia mice, which are deficient in the transcription factor Pitx3, model the selective nigrostriatal DA loss in PD. Here we report that aphakia mice are impaired in striatum-dependent cognitive tasks including rotarod learning, T-maze and inhibitory avoidance tasks, but not the striatum-independent social transmission of food preference task. These results suggest that some neuropsychiatric symptoms in PD are related to the pathophysiology of the disease rather than stress associated with disease burden, or medications used to treat PD. Furthermore aphakia mice may be used as a novel model of non-motor symptoms in PD.
Parkinson's disease is often characterized as a movement disorder, however, studies show that frequently major complaints of patients with PD are the non-motor and neuropsychiatric symptoms such as cognitive impairment, depression, anxiety and sleep disturbances. Interestingly, these cognitive symptoms can have a greater impact on quality of life measures than the hallmark motor symptoms of PD (Lauterbach, 2005) . Up to 80% of patients with PD show symptoms of cognitive impairment ranging from frank dementia and executive dysfunction to more subtle memory loss (Agid et al., 1986; Bosboom and Stoffers, 2004; Zgaljardic and Foldi, 2004; Bronnick and Aarsland, 2005) . Several hypotheses have been proposed to account for these non-motor neuropsychiatric symptoms which occur in PD. Briefly, these hypotheses have attributed non-motor symptoms such as cognitive impairment in PD to (1) stress related to coping with a chronic illness, (2) medications used to treat PD, or (3) events intrinsic to the pathophysiology of PD.
In the present studies we set out to test this third hypothesis. If it is the case that cognitive symptoms of PD are related to the disease process then animal models that mimic specific aspects of the pathophysiology of PD should also show impairments in cognitive function. Despite this prediction, cognitive aspects of PD have been difficult to study preclinically since animal models generated using toxin-based methods often have severe motor impairments which prevent the normal mobility required to perform typical cognitive tests in animals (Bove and Prou, 2005) . Thus the three above hypotheses have not been tested in animal models. It would be of great interest to have a model of cognitive aspects of PD to test potential therapeutics and investigate the neurobiology of cognitive symptoms of PD. Ideally, such a model would recapitulate important aspects of PD, but subjects would not be severely motor impaired so as to enable them to perform common behavioral tasks.
Over the last decade several genes have been identified that may play a role in dopamine neuron development as well as the pathophysiology of PD including Nurr1, Parkin, and Pitx3. Recently, we and others have shown that aphakia (ak) mice, which are deficient in the bicoid-related, homeodomain-containing transcription factor, Pitx3, fulfill major criteria for an animal model of PD. Pitx3 is restrictively expressed in the lens and midbrain and has been shown to play a key role in dopamine neuron development (Smidt et al., 2004a) . Consistent with an important role of Pitx3 in dopamine neuron development, Pitx3-deficient ak mice are the first genetic model to recapitulate selective nigrostriatal (A9) dopamine neuron loss (Hwang and Ardayfio, 2003; Nunes and Tovmasian, 2003; van den Munckhof and Luk, 2003; Smidt et al., 2004a) . Greater than 90% loss of A9 dopamine neurons occurs in ak mice, whereas A10 and other areas are less affected. Further validitation of the PD-like phenotype in this genetic model is that ak mice show impaired performance on select motor tests, which is reversible with L-Dopa (Hwang and Fleming, 2005) . 
